BRIEF-United Therapeutics Announces Positive Results From Phase 1 Study Of Miroliverelap In Patients With Acute Liver Failure
Reuters
Jan 26
BRIEF-United Therapeutics Announces Positive Results From Phase 1 Study Of Miroliverelap In Patients With Acute Liver Failure
Jan 26 (Reuters) - United Therapeutics Corp UTHR.O:
UNITED THERAPEUTICS ANNOUNCES POSITIVE RESULTS FROM PHASE 1 STUDY OF MIROLIVERELAP® IN PATIENTS WITH ACUTE LIVER FAILURE
UNITED THERAPEUTICS CORP - STUDY MET PRIMARY ENDPOINT OF SURVIVAL DURING TREATMENT
UNITED THERAPEUTICS CORP - NO UNEXPECTED SERIOUS ADVERSE EVENTS REPORTED
Source text: ID:nBw3mnsnza
Further company coverage: UTHR.O
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.